Top Story

Harvoni induces high response rates in genotype 4, 5 HCV

April 25, 2015

VIENNA — Patients with genotype 4 and 5 hepatitis C virus benefitted from treatment with Harvoni, according to findings presented at the 2015 International Liver Congress.

Armand Abergel, MD, of Médecine digestive, Chu Estaing at Université d'Auvergne, Clermont Ferrand in France, and colleagues treated more than 80 patients with 12 weeks of Harvoni (ledipasvir/sofosbuvir, Gilead Sciences) at five sites in France. “The cohort was a combination of treatment-naive and treatment-experienced patients,” he said. Half of the cohort had compensated cirrhosis.

VIDEO: C-SURFER: Patients with kidney disease, HCV achieve high rates of SVR Meeting News CoverageVideo

VIDEO: C-SURFER: Patients with kidney disease, HCV achieve high rates of SVR

April 25, 2015
VIENNA — Howard Monsour Jr., MD, chief of hepatology, Houston Methodist Hospital, Texas, discussed results of the C-SURFER trial, where 99% of patients with…
Meeting News Coverage

C-SWIFT: 8 weeks of therapy may be possible with grazoprevir/elbasvir

April 25, 2015
VIENNA — Patients with cirrhosis as well as genotype 1 and genotype 3 HCV responded favorably to 8 weeks of treatment with a novel grazoprevir and elbasvir-based…
Chikungunya common among US volunteers in Dominican Republic Meeting News Coverage

Chikungunya common among US volunteers in Dominican Republic

April 24, 2015
Infection with chikungunya was common among a group of United States volunteers working in the Dominican Republic during a large outbreak there, according to recent…
Jonathan Mermin In the Journals

HIV infections surge in Indiana

April 24, 2015
INDIANA — Indiana Gov. Mike Pence issued a second 30-day public health disaster emergency today as state and federal health care agencies attempt to contain a…
More News Headlines »
CME
Regimen Selection in HIV

Regimen Selection in HIV: Considering New Options to Optimize Outcomes
Monograph

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

More than 2 decades into the antiretroviral therapy (ART) era, numerous options are available for HIV treatment. The…
More »
Meeting News Coverage Video
VIDEO: Effectiveness of inactivated vs. live flu vaccine currently unclear

VIDEO: Effectiveness of inactivated vs. live flu vaccine currently unclear

April 24, 2015
BETHESDA, Md. — Richard K. Zimmerman, MD, of the University of Pittsburgh, explains the results of his study…
More »
CME
Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

This activity is supported by an educational grant from Alcon Research, LTD.

More »
morganatic-roan
morganatic-roan